KRAS and non-small cell lung carcinoma: The latter are the well-established NSCLC driver genes, KRAS (ECCC 0.71–0.90; 3 probe sets) and EGFR (ECCC 0.71–0.88; 3 probe sets), as well as the p53-targeting E3 ubiquitin ligase MDM2 (ECCC: 0.78–0.85; 5 probe sets).